Response rates for entire cohort (N = 38) and per protocol response evaluable patients (n = 36)
| Type of response . | Patients, n . | Entire cohort, % . | Response evaluable, % . |
|---|---|---|---|
| CR | 1 | 2.6% | 2.8% |
| PR | 6 | 15.7% | 16.6% |
| SD > 6 months | 5 | 13.2% | 13.9% |
| ORR (CR + PR) | 7 | 18.4% | 19.4% |
| Cytostatic ORR (CR + PR + SD ≥ 6 mo) | 12 | 31.6% | 33.3% |
| Type of response . | Patients, n . | Entire cohort, % . | Response evaluable, % . |
|---|---|---|---|
| CR | 1 | 2.6% | 2.8% |
| PR | 6 | 15.7% | 16.6% |
| SD > 6 months | 5 | 13.2% | 13.9% |
| ORR (CR + PR) | 7 | 18.4% | 19.4% |
| Cytostatic ORR (CR + PR + SD ≥ 6 mo) | 12 | 31.6% | 33.3% |